$ESPR the thing is: how many startup biotech companies like esperion could get through all phases and have an own drug at the end ? Right, around 10% . So esperion exists already over 20+ years, its clear tim mayleben can leave now company with a good conscience and image- but if he really wants the riskier way he can lose all or win big. Whatever he chooses, he should know when to EXIT! And i hope he is clever enough to see that.
3
3 Likes